News
4d
ScienceAlert on MSNGold Injections in The Eye May Be The Future of Vision PreservationGold dust in eyes might seem like an unusual therapy – but a new mouse study in the US shows the approach could potentially ...
Syfovre (pegcetacoplan) is a prescription injection used in adults to treat geographic atrophy due to a certain type of age-related macular degeneration (AMD). Syfovre comes as a solution that’s ...
3d
MedPage Today on MSNAlternative to Anti-VEGF Shows Safety, Efficacy in Diabetic Macular EdemaHe pointed out that frequent anti-VEGF injections into the eye can be a significant burden, and many patients with DME are of ...
Anti-VEGF therapy is effective for neovascular age-related macular degeneration (AMD); however, there are patients who fail to respond to monotherapy alone. Angiogenesis is a complex process that ...
Among the forms of monogenic macular degeneration ... early enough and people have retained a sufficient number of retinal cells, the therapy could prevent further degeneration. This makes it ...
Researchers use gold nanoparticles to restore vision in mice, offering hope for treating retinal disorders like macular ...
10d
Pharmaceutical Technology on MSNFDA to review Regeneron’s sBLA for aflibercept injection 8mgThe FDA has accepted Regeneron Pharmaceuticals’ sBLA for Eylea HD (aflibercept) injection 8mg for priority review.
photodynamic therapy with verteporfin and surgical treatments. Based on the scientific progress achieved in the past few years, it is possible that patients with myopic macular degeneration ...
News Medical on MSN11d
Golden eyes: How gold nanoparticles may one day help to restore people’s visionA team of Brown University researchers has identified a promising new approach that may one day help to restore vision in ...
6d
News-Medical.Net on MSNNew research aims to illuminate the causes of age-related macular degenerationAge-related macular degeneration begins with weakening of retinal pigment epithelium cells (RPEs), a layer of cells that support the retina's photoreceptors. When degeneration occurs, the affected ...
FDA Grants Priority Review to Regeneron’s Eylea for Macular Edema Following Retinal Vein Occlusion
Regulatory action was based on data from the Phase III QUASAR trial, which demonstrated that Eylea HD dosed every eight weeks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results